Mojca Stegnar

The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement

Darja Herman, Polona Peternel, Mojca Stegnar et al. · Thrombosis and Haemostasis · 2006 · 121 citations

Genetics, Genetic Epidemiology, Factor Vii +18

Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose

Darja Herman, Igor Locatelli, Iztok Grabnar et al. · The Pharmacogenomics Journal · 2005 · 121 citations

Thrombosis, Cardiovascular Disease, Genetic Epidemiology +11

Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese Women

Alenka Mavri, Mojca Stegnar, Michael Krebs et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 103 citations · Full text

A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS

Nelly Grubic, Mojca Stegnar, Polona Peternel et al. · Thrombosis Research · 1996 · 86 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +9

3,4-Dihydro-2<i>H</i>-1,4-benzoxazine Derivatives Combining Thrombin Inhibitory and Glycoprotein IIb/IIIa Receptor Antagonistic Activity as a Novel Class of Antithrombotic Compounds with Dual Function

Janez Ilaš, Žiga Jakopin, Tina Borštnar et al. · Journal of Medicinal Chemistry · 2008 · 63 citations · Full text

Thrombin S2, Thrombin Inhibitors, Pharmacotherapy +19